Dabigatran Etexilate Capsule, Coated Pellets
Product Images NDC 50090-7657

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dabigatran Etexilate (NDC 50090-7657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dab-igatran-fig1 (Dab Igatran Fig1)

FDA Label Image

Dab-igatran-fig2 (Dab Igatran Fig2)

This text provides information about the aPTT time course and the dosage of Dabigatran etexilate based on the patient's blood clotting time. The recommended dosage is 160 mg twice a day when the aPTT time is greater than 20 minutes and 75 mg twice a day when the aPTT time is less than 30 minutes.*

FDA Label Image

Dab-igatran-fig3-1 (Dab Igatran Fig3 1)

FDA Label Image

Dab-igatran-fig3-2 (Dab Igatran Fig3 2)

FDA Label Image

Dab-igatran-fig4 (Dab Igatran Fig4)

Not available.*

FDA Label Image

Dab-igatran-fig5 (Dab Igatran Fig5)

FDA Label Image

Dab-igatran-structure (Dab Igatran Structure)

FDA Label Image

Label Image (Lbl500907657)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.